Strong Revenue Growth
Butterfly Network reported a 33% year-over-year increase in revenue for Q3 2024, marking the fifth consecutive quarter where expectations were met or exceeded.
iQ3 Product Success
The iQ3 product accounted for over 50% of total volume, with over 80% of sales being domestic.
International Expansion
Butterfly Network expanded into new markets including Indonesia, Netherlands, and Belgium, and successfully launched iQ3 in Europe.
Strategic Partnerships
Continued partnership success with institutions like the University of Rochester Medical Center, which is improving patient care and clinical operations.
Product Innovations
Announced P5 chip with harmonic imaging capabilities, a significant advancement in digital ultrasound technology.
Financial Guidance Raised
Guidance for 2024 revenue increased to $79-$81 million, with EBITDA losses expected to improve to $40-$42 million.
Launch of OCTIV Subsidiary
New subsidiary to focus on commercializing Butterfly's semiconductor technology across various industries.